Document is current
Any future updates will be listed below
-
Authors
Shiers, Stephanie I. https://orcid.org/0000-0002-9646-1850
Mazhar, Khadijah
Wangzhou, Andi
Haberberger, Rainer https://orcid.org/0000-0001-8043-3786
Lesnak, Joseph B. https://orcid.org/0000-0002-4098-9090
Ezeji, Nwasinachi A.
Sankaranarayanan, Ishwarya
Tavares-Ferreira, Diana https://orcid.org/0000-0003-0986-3630
Cervantes, Anna
Funk, Geoffrey https://orcid.org/0000-0001-6875-6777
Horton, Peter
Vines, Erin
Dussor, Gregory
Price, Theodore J. https://orcid.org/0000-0002-6971-6221
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (U19NS130608, R01NS111929)
- License Information
-
More Information
Article History
Received: 20 September 2024
Accepted: 23 April 2025
First Online: 5 May 2025
Competing interests
: T.J.P. is a co-founder of 4E Therapeutics. The authors declare no other competing interests related to this work.
